TOP STORIES

• REGULATORY MHLW Sets Interim Nitrosamine Limit for Atomoxetine, 5 Generic Makers Launch Fresh Recalls
  October 23, 2025

• REGULATORY Public-Private WG to Compile Industry Proposals on Drug Pricing Reforms at Next Session
  October 23, 2025

• ORGANIZATION MFN Drug Pricing Already Affecting 4 Firms’ R&D Plans in Japan, EFPIA Chief Flags Fallout
  October 22, 2025

• REGULATORY LDP, Nippon Ishin to Form Coalition; OTC-Like Drug Copay Review Set for FY2025
  October 21, 2025

• BUSINESS Chiesi Japan to Expand Workforce Tenfold by 2030 on Back of New Drug Filings
  October 20, 2025

• REGULATORY MHLW Panel Launches Full Debate on Drug Coverage Reform; LLPs, Biologics, OTC-Like Meds in Focus
  October 17, 2025

• BUSINESS Viatris Snaps Up Japan’s Aculys Pharma, Gains 2 CNS Assets
  October 17, 2025

• BUSINESS Organon Bids Farewell to 1990s Blockbusters Lipovas and Renivace in Japan
  October 16, 2025

• REGULATORY Deeper CEA Price Cuts Mooted for “Cost Increase” Products: FY2026 Reform Debate
  October 16, 2025

• REGULATORY Chuikyo Urges Stricter Pricing Rules for Conditionally Approved Regenerative Medicines
  October 16, 2025

• BUSINESS Kite Looks to Expand Japan CAR-T Footprint, Boosts Supply Infrastructure
  October 15, 2025

• REGULATORY Komeito’s Exit from Ruling Coalition Casts Uncertainty over Japan’s Drug Policy
  October 15, 2025

• REGULATORY MHLW to Clarify Criteria for Japanese PI Waivers through Q&A, Calls for Data-Based Justifications
  October 14, 2025

• REGULATORY GS1 Barcode Adoption Stalls at 40% of Hospitals, Pharmacist Urges Subsidies
  October 10, 2025

• REGULATORY Japan Launches Study on Legal Framework for Patent Linkage System
  October 9, 2025

• REGULATORY Chuikyo Frowns on Industry Calls for Scrapping Huge-Seller Re-Pricing, Spillovers
  October 9, 2025

• BUSINESS NHI-Market Price Gap Likely to Narrow Further in 2025; Will It Drop into 4% Zone?
  October 8, 2025

• BUSINESS Leqembi Iqlik Autoinjector Now Available in US: Eisai/Biogen
  October 8, 2025

• COMMENTARY Inside Eylea - 2: Will a Bio-AG Return after Six Years? Pricing Debate Resumes
  October 7, 2025

• ACADEMIA Japan’s Sakaguchi Wins 2025 Nobel Prize in Medicine
  October 7, 2025

ページ

• « 先頭
• ‹ Prev
• …
• 15
• 16
• 17
• 18
• 19
• 20
• 21
• 22
• 23
• …
• Next ›
• 最終 »